Commitments and Contingencies (Details Narrative)
|
12 Months Ended |
|
Dec. 31, 2022
USD ($)
|
|---|
| Onxeo S.A |
|
| Option And License Agreement Description |
the option agreement includes clinical, regulatory, developmental and sales milestones that could reach up to $108 million if the Company achieves all milestones, and escalating royalties on net sales from 5% to 10%
|
| XOMA Ltd |
|
| Option And License Agreement Description |
regulatory and sales milestones for MNPR-101 that could reach up to $14.925 million if the Company achieves all milestones
|
| GEIS |
|
| Clinical-related Expenses |
$ 300,000
|
| 1,202 square feet [Member] |
|
| Operating Lease Monthly Payment |
2,379
|
| Additional Office Space [Member] |
|
| Operating Lease Monthly Payment |
1,859
|
| Level 1 |
|
| Operating Lease Monthly Payment |
$ 4,238
|